Satellos Bioscience (MSLE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $6.84, +3.17% vs the prior close of $6.63.
- Volume 79.90K shares, 1.9x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MSLE jumps 3.2% to $6.84 on 1.9x normal volume. Closed at $6.84, +3.17% vs the prior close of $6.63. Day range $6.51–$7.06, opened at $6.68.
MSLE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MSLE jumps 3.2% to $6.84 on 1.9x normal volume
- Closed at $6.84, +3.17% vs the prior close of $6.63. Day range $6.51–$7.06, opened at $6.68.
- Volume was 79.90K shares, 1.9x its 50-day average of 43.06K — unusually heavy trading.
- Price is -24.1% vs its 50-day average ($9.01) and -19.4% vs its 200-day average ($8.49).
- 52-week range $5.30–$13.40; today's close sits at 19% of that range, 48.9% below the 52-week high.
Oct 14, 2026 — MSLE slides 5.8% to $6.63, a 3-month low, 3 down days in a row
- Closed at $6.63, -5.82% vs the prior close of $7.04. Day range $6.51–$7.14, opened at $7.14.
- Volume was 43.80K shares, 1.0x its 50-day average of 43.04K.
- Price is -26.9% vs its 50-day average ($9.08) and -21.9% vs its 200-day average ($8.48).
- 52-week range $5.30–$13.40; today's close sits at 16% of that range, 50.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — MSLE dips 1.8% to $7.04, a 3-month low on 2.2x normal volume
- Closed at $7.04, -1.81% vs the prior close of $7.17. Day range $6.88–$7.45, opened at $7.16.
- Volume was 92.90K shares, 2.2x its 50-day average of 42.17K — unusually heavy trading.
- Price is -23.0% vs its 50-day average ($9.14) and -17.0% vs its 200-day average ($8.48).
- 52-week range $5.30–$13.40; today's close sits at 21% of that range, 47.4% below the 52-week high.
Oct 12, 2026 — MSLE slides 4.3% to $7.17, a 3-month low
- Closed at $7.17, -4.27% vs the prior close of $7.49. Day range $7.07–$7.58, opened at $7.58.
- Volume was 66.00K shares, 1.6x its 50-day average of 41.58K.
- Price is -22.1% vs its 50-day average ($9.20) and -15.4% vs its 200-day average ($8.48).
- 52-week range $5.30–$13.40; today's close sits at 23% of that range, 46.5% below the 52-week high.
Oct 9, 2026 — MSLE rises 2.0% to $7.49
- Closed at $7.49, +1.97% vs the prior close of $7.34. Day range $7.29–$7.74, opened at $7.30.
- Volume was 59.90K shares, 1.5x its 50-day average of 40.61K.
- Price is -19.1% vs its 50-day average ($9.25) and -11.6% vs its 200-day average ($8.47).
- 52-week range $5.30–$13.40; today's close sits at 27% of that range, 44.1% below the 52-week high.
Oct 8, 2026 — MSLE slides 3.7% to $7.34, a 3-month low on 3.1x normal volume
- Closed at $7.34, -3.74% vs the prior close of $7.63. Day range $7.25–$8.08, opened at $8.08.
- Volume was 121.40K shares, 3.1x its 50-day average of 38.85K — unusually heavy trading.
- Price is -21.0% vs its 50-day average ($9.30) and -13.2% vs its 200-day average ($8.46).
- 52-week range $5.30–$13.40; today's close sits at 25% of that range, 45.2% below the 52-week high.
Oct 7, 2026 — MSLE rises 1.2% to $7.63
- Closed at $7.63, +1.19% vs the prior close of $7.54. Day range $7.44–$8.35, opened at $7.70.
- Volume was 47.70K shares, 1.2x its 50-day average of 38.55K.
- Price is -18.3% vs its 50-day average ($9.34) and -9.7% vs its 200-day average ($8.45).
- 52-week range $5.30–$13.40; today's close sits at 29% of that range, 43.0% below the 52-week high.
Oct 6, 2026 — MSLE slides 6.3% to $7.54, a 3-month low, 6 down days in a row
- Closed at $7.54, -6.34% vs the prior close of $8.05. Day range $7.54–$8.38, opened at $8.08.
- Volume was 48.10K shares, 1.3x its 50-day average of 38.22K.
- Price is -19.6% vs its 50-day average ($9.38) and -10.7% vs its 200-day average ($8.45).
- 52-week range $5.30–$13.40; today's close sits at 28% of that range, 43.7% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — MSLE slides 5.3% to $8.05, a 3-month low, 5 down days in a row
- Closed at $8.05, -5.29% vs the prior close of $8.50. Day range $8.05–$8.60, opened at $8.46.
- Volume was 24.80K shares, 0.6x its 50-day average of 38.56K.
- Price is -14.5% vs its 50-day average ($9.41) and -4.6% vs its 200-day average ($8.44).
- 52-week range $5.30–$13.40; today's close sits at 34% of that range, 39.9% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: 6-K.
Oct 2, 2026 — MSLE ends flat (+0.0%) to $8.50, 4 down days in a row
- Closed at $8.50, +0.00% vs the prior close of $8.50. Day range $8.32–$8.73, opened at $8.56.
- Volume was 27.70K shares, 0.7x its 50-day average of 40.18K.
- Price is -10.0% vs its 50-day average ($9.45) and +0.9% vs its 200-day average ($8.43).
- 52-week range $5.30–$13.40; today's close sits at 40% of that range, 36.5% below the 52-week high.
- That makes 4 straight losses.
MSLE latest news & SEC filings
Every SEC filing by or about MSLE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade MSLE
- How much it moves: over the last 20 sessions the average daily move was 2.79% (largest 6.3%).
- Liquidity: about 72.14K shares (≈$493.40K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.84 vs a range of $5.30–$13.40 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:12 on Jan 30, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 5, 2026; 6-K Sep 30, 2026; 6-K Sep 24, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MSLE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 6.68 | 7.06 | 6.51 | 6.84 | 79.90K |
| Oct 14, 2026 | 7.14 | 7.14 | 6.51 | 6.63 | 43.80K |
| Oct 13, 2026 | 7.16 | 7.45 | 6.88 | 7.04 | 92.90K |
| Oct 12, 2026 | 7.58 | 7.58 | 7.07 | 7.17 | 66.00K |
| Oct 9, 2026 | 7.30 | 7.74 | 7.29 | 7.49 | 59.90K |
| Oct 8, 2026 | 8.08 | 8.08 | 7.25 | 7.34 | 121.40K |
| Oct 7, 2026 | 7.70 | 8.35 | 7.44 | 7.63 | 47.70K |
| Oct 6, 2026 | 8.08 | 8.38 | 7.54 | 7.54 | 48.10K |
| Oct 5, 2026 | 8.46 | 8.60 | 8.05 | 8.05 | 24.80K |
| Oct 2, 2026 | 8.56 | 8.73 | 8.32 | 8.50 | 27.70K |
| Oct 1, 2026 | 8.51 | 8.94 | 8.30 | 8.50 | 80.00K |
| Sep 30, 2026 | 8.60 | 8.82 | 8.45 | 8.50 | 89.20K |
| Sep 29, 2026 | 8.67 | 8.85 | 8.35 | 8.60 | 433.30K |
| Sep 28, 2026 | 8.51 | 9.03 | 8.51 | 8.81 | 48.10K |
| Sep 25, 2026 | 8.77 | 8.86 | 8.53 | 8.70 | 37.40K |
| Sep 24, 2026 | 8.50 | 8.77 | 8.36 | 8.71 | 41.00K |
| Sep 23, 2026 | 8.84 | 8.86 | 8.41 | 8.41 | 43.00K |
| Sep 22, 2026 | 9.16 | 9.43 | 8.82 | 8.87 | 26.80K |
| Sep 21, 2026 | 9.31 | 9.47 | 9.16 | 9.18 | 11.90K |
| Sep 18, 2026 | 9.72 | 9.75 | 9.31 | 9.32 | 19.80K |
About Satellos Bioscience
Satellos Bioscience (MSLE) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MARKHAM. State of incorporation: Canada (Federal Level). Fiscal year ends December 31. SEC CIK 1421642.
MSLE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MSLE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
MSLE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MSLE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.